Literature DB >> 3955560

Cardiotoxicity associated with 4'-deoxydoxorubicin.

D Blayney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3955560

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report.

Authors:  Q S Ringenberg; K J Propert; H B Muss; R B Weiss; R L Schilsky; C Modeas; M C Perry; L Norton; M Green
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850

2.  Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).

Authors:  H Hochster; M Hunt; M Green; D Parkinson; T Smith
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

Review 3.  Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature.

Authors:  L F Diehl; A Banks; W Carter; M A Klein; H B Muss; R B Weiss
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.